The Bitter Barricading of Prostaglandin Biosynthesis Pathway: Understanding the Molecular Mechanism of Selective Cyclooxygenase-2 Inhibition by Amarogentin, a Secoiridoid Glycoside from Swertia chirayita

Abstract

Swertia chirayita, a medicinal herb inhabiting the challenging terrains and high altitudes of the Himalayas, is a rich source of essential phytochemical isolates. Amarogentin, a bitter secoiridoid glycoside from S. chirayita, shows varied activity in several patho-physiological conditions, predominantly in leishmaniasis and carcinogenesis. Experimental analysis has revealed that amarogentin downregulates the cyclooxygenase-2 (COX-2) activity and helps to curtail skin carcinogenesis in mouse models; however, there exists no account on selective inhibition of the inducible cyclooxygenase (COX) isoform by amarogentin. Hence the computer-aided drug discovery methods were used to unravel the COX-2 inhibitory mechanism of amarogentin and to check its selectivity for the inducible isoform over the constitutive one. The generated theoretical models of both isoforms were subjected to molecular docking analysis with amarogentin and twenty-one other Food and Drug Authority (FDA) approved lead molecules. The post-docking binding energy profile of amarogentin was comparable to the binding energy profiles of the FDA approved selective COX-2 inhibitors. Subsequent molecular dynamics simulation analysis delineated the difference in the stability of both complexes, with amarogentin-COX-2 complex being more stable after 40ns simulation. The total binding free energy calculated by MMGBSA for the amarogentin-COX-2 complex was −52.35 KCal/mol against a binding free energy of −8.57 KCal/mol for amarogentin-COX-1 complex, suggesting a possible selective inhibition of the COX-2 protein by the natural inhibitor. Amarogentin achieves this potential selectivity by small, yet significant, structural differences inherent to the binding cavities of the two isoforms. Hypothetically, it might block the entry of the natural substrates in the hydrophobic binding channel of the COX-2, inhibiting the cyclooxygenation step. To sum up briefly, this work highlights the mechanism of the possible selective COX-2 inhibition by amarogentin and endorses the possibility of obtaining efficient, futuristic and targeted therapeutic agents for relieving inflammation and malignancy from this phytochemical source.

Anti-inflammatory potential of mushroom extracts and isolated metabolites

“…Considerable resources have thus been invested in the pharmaceutical industries for development and design of drugs that act through selective inhibition of COX-2 to control inflammation with improved tolerability, less adverse effects, and without affecting normal metabolic processes (Shukla, Bafna, Sundar, & Thorat, 2014 Several in vitro measurement of NO production in LPS stimulated RAW 264.7 cells have been reported by several authors in the past, and this is one of the possible ways to screen various extracts and bioactive compounds with potential anti-inflammatory properties. RAW 264.7 cells are seeded in 96-well plates, they are then treated with different concentrations of the sample to be studied followed by stimulation with LPS.…”

Natural plant products as potential inhibitors of RNA dependent RNA polymerase of Severe Acute Respiratory Syndrome Coronavirus-2

“…SWE is a xanthone glycoside known to have anti-viral properties [ 66 ]. AMR is a bitter secoiridoids glycoside, which possess anti-microbial properties [ 67 ]. SIT is a glycowithanolide known to have antineoplastic activity [ 68 ].…”

Potential mechanistic profiling of an otc analgesic as a cytotoxic agent in the treatment of hepatocellular carcinoma

“…When such residues are present in close vicinity of the ligand molecule, they exert a coulombic force at a shorter distance. On examination of the interactions made by paracetamol with COX-1, CDK-2 and BCRA2, it was noticed that while the latter formed multiple electrostatic interactions, the first and the second failed to contact any positive or negative residues 34,35 .…”